ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 390 filers reported holding ASTRAZENECA PLC in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,473,000 | +190.2% | 167,674 | +163.2% | 0.40% | +167.8% |
| Q1 2019 | $2,575,000 | +99.8% | 63,700 | +95.4% | 0.15% | +231.1% |
| Q3 2018 | $1,289,000 | +40.7% | 32,600 | +24.9% | 0.04% | +136.8% |
| Q2 2018 | $916,000 | -88.7% | 26,100 | -88.7% | 0.02% | -86.4% |
| Q1 2018 | $8,095,000 | -35.3% | 231,500 | -35.8% | 0.14% | -23.9% |
| Q4 2017 | $12,512,000 | +390.9% | 360,600 | +364.7% | 0.18% | +119.0% |
| Q3 2016 | $2,549,000 | +164.1% | 77,600 | +126.2% | 0.08% | +78.7% |
| Q1 2016 | $965,000 | -45.8% | 34,300 | -34.7% | 0.05% | -56.5% |
| Q4 2015 | $1,782,000 | +24.0% | 52,500 | +150.0% | 0.11% | -21.7% |
| Q1 2015 | $1,437,000 | +335.5% | 21,000 | +311.8% | 0.14% | +762.5% |
| Q1 2014 | $330,000 | -69.7% | 5,100 | -75.7% | 0.02% | -83.5% |
| Q3 2013 | $1,090,000 | -31.6% | 21,000 | -37.7% | 0.10% | -65.5% |
| Q2 2013 | $1,594,000 | – | 33,700 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |